Search

everythinglearnresearchcommunity

for

Search:↓

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

Using old drugs for new uses can help treat rare immune deficiencies.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Spironolactone does not increase the risk of breast cancer recurrence.

Low-dose oral minoxidil can effectively treat hair loss.

Bimatoprost 0.03% helps grow eyebrow hair.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Low-dose oral minoxidil is being revisited as a promising hair loss treatment.

Most American men experience hair loss by age 50, with limited effective treatments available and new options not expected soon.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

The document concludes that proper treatment and management of plaque psoriasis in adolescents can improve their quality of life.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

New treatments for male pattern hair loss look promising, but established treatments are still the main option.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Bicalutamide may help treat female pattern hair loss.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.